(Q36643550)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17082808%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

review article

1 reference

title

The role of oxyntomodulin and peptide tyrosine-tyrosine (PYY) in appetite control (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17082808%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17082808%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

author name string

Stephen R Bloom

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17082808%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

publication date

1 November 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17082808%20AND%20SRC:MED&resulttype=core&format=json

Nature Clinical Practice Endocrinology and Metabolism

21 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17082808%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

volume

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17082808%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

issue

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17082808%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

page(s)

612-620

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17082808%20AND%20SRC:MED&resulttype=core&format=json

Expression of ileal glucagon and peptide tyrosine-tyrosine genes. Response to inhibition of polyamine synthesis in the presence of massive small-bowel resection

21 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0318

Human distribution and release of a putative new gut hormone, peptide YY

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0318

Repeated ICV administration of oxyntomodulin causes a greater reduction in body weight gain than in pair-fed rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0318

Peptide YY(3-36) inhibits gastric emptying and produces acute reductions in food intake in rhesus monkeys.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0318

Hormonal regulation of food intake.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0318

7 January 2021

Isolation of two novel candidate hormones using a chemical method for finding naturally occurring polypeptides

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0318

7 January 2021

Bioactive enteroglucagon (oxyntomodulin): Present knowledge on its chemical structure and its biological activities

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0318

7 January 2021

Inhibition of food intake in obese subjects by peptide YY3-36

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0318

7 January 2021

Subcutaneous oxyntomodulin reduces body weight in overweight and obese subjects: a double-blind, randomized, controlled trial

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0318

7 January 2021

Gastrointestinal hormones and food intake

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0318

7 January 2021

Comparison of the postprandial release of peptide YY and proglucagon-derived peptides in the rat

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0318

7 January 2021

Oxyntomodulin: a potential hormone from the distal gut. Pharmacokinetics and effects on gastric acid and insulin secretion in man

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0318

7 January 2021

Effect of peptide YY on gastric, pancreatic, and biliary function in humans.

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0318

7 January 2021

Effects of peptide YY and neuropeptide Y on gastric emptying in man

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0318

7 January 2021

Effect of circulating peptide YY on gallbladder emptying in humans.

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0318

7 January 2021

Glucagon-like peptide containing pathways in the regulation of feeding behaviour

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0318

7 January 2021

Glucagon-like Peptide 1 (GLP-1): An Intestinal Hormone, Signalling Nutritional Abundance, with an Unusual Therapeutic Potential

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0318

7 January 2021

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0318

7 January 2021

Distribution of oxyntomodulin and glucagon in the gastrointestinal tract and the plasma of the rat

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0318

7 January 2021

Molecular forms of human enteroglucagon in tissue and plasma: plasma responses to nutrient stimuli in health and in disorders of the upper gastrointestinal tract

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0318

7 January 2021

Conformational flexibility in a small globular hormone: x-ray analysis of avian pancreatic polypeptide at 0.98-A resolution

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0318

7 January 2021

The origin and evolution of peptide YY (PYY) and pancreatic polypeptide (PP).

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0318

7 January 2021

Neuropeptide Y--a novel brain peptide with structural similarities to peptide YY and pancreatic polypeptide.

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0318

7 January 2021

Distribution of pancreatic polypeptide and peptide YY

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0318

7 January 2021

Cholecystokinin and peptide YY are released by fat in either proximal or distal small intestine in dogs

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0318

7 January 2021

Fat digestion is required for suppression of ghrelin and stimulation of peptide YY and pancreatic polypeptide secretion by intraduodenal lipid

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0318

7 January 2021

Mechanisms of peptide YY release induced by an intraduodenal meal in rats: neural regulation by proximal gut

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0318

7 January 2021

Two molecular forms of peptide YY (PYY) are abundant in human blood: characterization of a radioimmunoassay recognizing PYY 1-36 and PYY 3-36

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0318

7 January 2021

Proteolytic processing of neuropeptide Y and peptide YY by dipeptidyl peptidase IV

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0318

7 January 2021

The multifunctional or moonlighting protein CD26/DPPIV.

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0318

7 January 2021

The role of dipeptidyl peptidase IV in the cleavage of glucagon family peptides: in vivo metabolism of pituitary adenylate cyclase activating polypeptide-(1-38).

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0318

7 January 2021

Oxyntomodulin inhibits food intake in the rat

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0318

7 January 2021

Peripheral oxyntomodulin reduces food intake and body weight gain in rats.

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0318

7 January 2021

Acute effects of PYY3-36 on food intake and hypothalamic neuropeptide expression in the mouse.

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0318

7 January 2021

Peptide YY3-36 inhibits food intake in mice through a melanocortin-4 receptor-independent mechanism

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0318

7 January 2021

Pre-obese and obese agouti mice are sensitive to the anorectic effects of peptide YY(3-36) but resistant to ghrelin

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0318

7 January 2021

Intravenous infusion of peptide YY(3-36) potently inhibits food intake in rats

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0318

7 January 2021

Effects of PYY[3-36] in rodent models of diabetes and obesity

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0318

7 January 2021

Peptide YY directly inhibits ghrelin-activated neurons of the arcuate nucleus and reverses fasting-induced c-Fos expression.

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0318

7 January 2021

Peripheral exendin-4 and peptide YY(3-36) synergistically reduce food intake through different mechanisms in mice

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0318

7 January 2021

Gut hormone PYY(3-36) physiologically inhibits food intake

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0318

7 January 2021

Lower mean weight after 14 days intravenous administration peptide YY3-36 (PYY3-36) in rabbits

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0318

7 January 2021

Peptide YY(3-36) inhibits morning, but not evening, food intake and decreases body weight in rhesus macaques

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0318

7 January 2021

PYY3-36 as an anti-obesity drug target.

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0318

7 January 2021

Does gut hormone PYY3–36 decrease food intake in rodents?

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0318

7 January 2021

Mice lacking pro-opiomelanocortin are sensitive to high-fat feeding but respond normally to the acute anorectic effects of peptide-YY(3-36).

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0318

7 January 2021

The importance of acclimatisation and habituation to experimental conditions when investigating the anorectic effects of gastrointestinal hormones in the rat.

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0318

7 January 2021

Entry of peroxidase into neurons of the central and peripheral nervous systems from extracerebral and cerebral blood

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0318

7 January 2021

The arcuate nucleus as a conduit for diverse signals relevant to energy homeostasis

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0318

7 January 2021

The hardship of obesity: a soft-wired hypothalamus

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0318

7 January 2021

Central nervous system control of food intake

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0318

7 January 2021

Oxyntomodulin and glucagon-like peptide-1 differentially regulate murine food intake and energy expenditure

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0318

7 January 2021

A role for glucagon-like peptide-1 in the central regulation of feeding

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0318

7 January 2021

Stable expression of the rat GLP-I receptor in CHO cells: activation and binding characteristics utilizing GLP-I(7-36)-amide, oxyntomodulin, exendin-4, and exendin(9-39)

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0318

7 January 2021

Analysis of neuropeptide Y-induced feeding: Dissociation of Y1 and Y2 receptor effects on natural meal patterns

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0318

7 January 2021

Normal feeding behavior, body weight and leptin response require the neuropeptide Y Y2 receptor.

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0318

7 January 2021

Blockade of the neuropeptide Y Y2 receptor with the specific antagonist BIIE0246 attenuates the effect of endogenous and exogenous peptide YY(3-36) on food intake

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0318

7 January 2021

Subtypes Y1 and Y2 of the neuropeptide Y receptor are respectively expressed in pro-opiomelanocortin- and neuropeptide-Y-containing neurons of the rat hypothalamic arcuate nucleus.

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0318

7 January 2021

Peptide YY(3-36) inhibits both anorexigenic proopiomelanocortin and orexigenic neuropeptide Y neurons: implications for hypothalamic regulation of energy homeostasis.

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0318

7 January 2021

Acute stress increases neuropeptide Y mRNA within the arcuate nucleus and hilus of the dentate gyrus

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0318

7 January 2021

Differential regulation of neuropeptide Y mRNA expression in the arcuate nucleus and locus coeruleus by stress and antidepressants

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0318

7 January 2021

The role of the vagal nerve in peripheral PYY3-36-induced feeding reduction in rats.

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0318

7 January 2021

Oxyntomodulin suppresses appetite and reduces food intake in humans

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0318

7 January 2021

Oxyntomodulin increases energy expenditure in addition to decreasing energy intake in overweight and obese humans: a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0318

7 January 2021

Effect of peptide YY3-36 on food intake in humans

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0318

7 January 2021

Gut hormones in tropical malabsorption

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0318

7 January 2021

Plasma Enteroglucagon after Jejunoileal Bypass with 3:1 or 1:3 Jejunoileal Ratio

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0318

7 January 2021

Peptide YY abnormalities in gastrointestinal diseases

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0318

7 January 2021

Gastrointestinal hormones and gastric emptying 20 years after jejunoileal bypass for massive obesity

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0318

7 January 2021

Peptide YY secretion in morbidly obese patients before and after vertical banded gastroplasty

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0318

7 January 2021

The putative satiety hormone PYY is raised in cardiac cachexia associated with primary pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0318

7 January 2021

Attenuated peptide YY release in obese subjects is associated with reduced satiety.

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0318

7 January 2021

A PYY Q62P variant linked to human obesity.

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0318

7 January 2021

Peptide YY3-36 and glucagon-like peptide-17-36 inhibit food intake additively.

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0318

7 January 2021

Reversible PEGylation of peptide YY3-36 prolongs its inhibition of food intake in mice.

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0318

7 January 2021

Glucagon-like peptide-1: from extract to agent. The Claude Bernard Lecture, 2005.

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0318

7 January 2021

Identifiers

DOI

10.1038/NCPENDMET0318

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17082808%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

1 reference